BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended December 31, 2025.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Balaxi Pharmaceuticals Limited has filed its financial results with the NSE for the quarter and nine months ended December 31, 2025. The announcement is a routine regulatory submission and does not include specific revenue, profit, or margin figures in the headline. Investors would need to review the detailed results document for actual performance numbers. No auditor opinion flags or restatement notes are mentioned in this filing.
No immediate stock price impact is expected from this announcement alone, as it is a standard quarterly results submission. Shareholders should review the detailed financials for any material changes in revenue, profitability, or guidance.